Pelvic Inflammatory Disease Clinical Trial
Official title:
Phase 4 Study of Azitromicin in the Treatment of PID
Objective: To compare two oral treatments: Ofloxacin + Metronidazole, and Azitromycin
+Metronidazole in outpatients with Pelvic Inflammatory Disease.
Materials and Methods: Two hundred patients divided to two groups( A , B). Group A (treated
by Ofloxacin 400 mg. + Metronidazole 500mg) and Group B (a single dose of oral Azitromicine
1gr + Metronidazole 500mg) for 10 days, were compared in terms of side effects and efficacy
Two hundred patients divided to two groups( A , B). Group A (treated by Ofloxacin 400 mg. + Metronidazole 500mg) and Group B (a single dose of oral Azitromicine 1gr + Metronidazole 500mg) for 10 days, were compared in terms of side effects and efficacy ;
Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04723069 -
Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases
|
Phase 2 | |
Recruiting |
NCT03391440 -
A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease
|
Phase 4 | |
Completed |
NCT01671280 -
Drug Use Investigation Of Azithromycin IV For Community-Acquired Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)
|
N/A | |
Completed |
NCT00115388 -
Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease
|
N/A | |
Not yet recruiting |
NCT02972151 -
Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae
|
Phase 2 | |
Completed |
NCT01236131 -
The Role of Novel Organisms in Acute Endometritis
|
N/A | |
Completed |
NCT01160640 -
The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
|
Phase 2 | |
Active, not recruiting |
NCT03994055 -
Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer
|
N/A | |
Completed |
NCT00871494 -
Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan
|
Phase 3 | |
Completed |
NCT00783419 -
Rate of Pelvic Inflammatory Disease at St. Michael's Hospital
|
||
Completed |
NCT01799356 -
Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials
|
Phase 4 | |
Recruiting |
NCT05408624 -
Pilot Study Evaluating Outpatient Management of Tubo-ovarian Abscesses
|
||
Completed |
NCT00453349 -
A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease
|
Phase 3 | |
Recruiting |
NCT04234945 -
Effect of Prophylactic Antibiotics for Hysterosalpingography on Post Procedure Morbidity
|
N/A | |
Recruiting |
NCT06360965 -
Clinical Trial of Acupoint Application in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pelvic Pain
|
N/A | |
Recruiting |
NCT05648747 -
Pelvic Inflammatory Disease in COVID-19 Era
|
||
Completed |
NCT01793584 -
Surgical Success After Laparoscopic vs Abdominal Hysterectomy
|
N/A | |
Completed |
NCT01299259 -
Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease
|
N/A | |
Completed |
NCT03054402 -
First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845
|
Phase 1 | |
Active, not recruiting |
NCT03828994 -
Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II
|
N/A |